Abstract
A commonly encountered problem within memory services is the identification of medications that cause cognitive side-effects. Here, the authors report on the findings of a clinical audit used to evaluate practice of medical staff against National Institute for Health and Care Excellence (NICE) guidance on the ‘assessment and diagnosis of dementia’. The audit highlights the importance of reviewing prescriptions of confusion-inducing drugs within memory services and barriers to improving clinical practice.
Cite
CITATION STYLE
Bowditch, E., Padmanathan, P., Martinez-Clavera, C., & Kuruvilla, T. (2018). Confusion-inducing drugs in a memory assessment service: An audit. Progress in Neurology and Psychiatry, 22(3), 15–18. https://doi.org/10.1002/pnp.508
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.